Study guide
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes
NBME Comprehensive Basic Science Examination CBSE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Navigation
1.1 Current Exam Facts & Administration 1.2 Content Blueprint & Physician Tasks 1.3 Scoring, Score Reports & Step 1 Readiness
2 Human Development
2.1 Embryology & Congenital Development Patterns 2.2 Normal Age-Related Findings & Well-Patient Care
3 Blood & Hematologic Disease
3.1 Hematopoiesis, RBC Disorders & Anemias 3.2 Hemostasis, Thrombosis & Coagulopathies 3.3 WBC Disorders, Leukemia & Lymphoma Mechanisms
4 Immune System
4.1 Innate & Adaptive Immunity Mechanisms 4.2 Hypersensitivity, Autoimmunity & Immunodeficiency 4.3 Transplant Immunology & Immune Pharmacology
5 Nervous System Anatomy & Disease
5.1 Neuroanatomy Localization & Pathways 5.2 Stroke, Infection, Demyelination & Trauma 5.3 Seizures, Movement Disorders & Neurodegeneration 5.4 Special Senses: Eye & Ear Mechanisms
6 Behavioral Health
6.1 Psychiatric Disorders & Diagnostic Patterns 6.2 Psychopharmacology Mechanisms 6.3 Neurotransmitters, Learning & Behavioral Science
7 Musculoskeletal System
7.1 Bone Physiology, Fracture Healing & Bone Pathology 7.2 Joint Disease, Rheumatology & Connective Tissue 7.3 Muscle, NMJ & Peripheral Nerve Disorders
8 Skin & Soft Tissue
8.1 Dermatopathology High-Yield Lesions 8.2 Inflammation, Wound Healing & Soft-Tissue Infection
9 Cardiovascular Pathophysiology
9.1 Cardiac Cycle, Hemodynamics & Murmurs 9.2 Ischemic Heart Disease & Cardiomyopathy 9.3 Congenital & Valvular Heart Disease 9.4 Vascular Pathology & Hypertension
10 Cardiovascular Pharmacology
10.1 Antihypertensives, Heart Failure & Antiarrhythmics 10.2 Antiplatelets, Anticoagulants & Lipid Drugs
11 Respiratory System
11.1 Pulmonary Mechanics & Gas Exchange 11.2 Obstructive, Restrictive & Vascular Lung Disease 11.3 Pulmonary Infections, Neoplasms & Respiratory Pharmacology
12 Renal Physiology & Electrolytes
12.1 Nephron Transport & Renal Physiology 12.2 Electrolyte Disorders 12.3 Acid-Base Physiology & Compensation
13 Renal Pathology
13.1 Glomerular Disease Mechanisms 13.2 Tubulointerstitial, Vascular & Stone Disease
14 Gastrointestinal System
14.1 GI Physiology, Motility & Digestion 14.2 Esophagus, Stomach & Intestinal Pathology 14.3 Liver, Biliary Tree & Pancreas 14.4 GI Microbiology, Nutrition & Malabsorption
15 Endocrine System
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes 15.2 Thyroid & Parathyroid Disease 15.3 Adrenal Disorders & Steroid Pharmacology 15.4 Diabetes, Glucose Homeostasis & Metabolic Syndrome
16 Reproductive System
16.1 Male & Female Reproductive Physiology 16.2 Pregnancy, Placenta & Developmental Toxicology 16.3 Reproductive Pathology & Hormone-Related Neoplasia
17 Multisystem Processes & Disorders
17.1 Cell Injury, Inflammation & Repair 17.2 Neoplasia Principles & Tumor Biology 17.3 Infection, Sepsis & Multisystem Microbial Disease 17.4 Genetics, Inborn Errors & Environmental Toxicology
18 Biostatistics & Epidemiology
18.1 Study Design, Bias & Causation 18.2 Diagnostic Test Metrics & Screening 18.3 Epidemiology Measures & Population Health
19 Social Sciences & Communication
19.1 Ethics Principles & Decision-Making Capacity 19.2 Communication Skills & Difficult Conversations 19.3 Professionalism, Systems & Practice-Based Learning
20 Integrated Disciplines Capstone
20.1 High-Yield Microbiology Anchors Across Systems 20.2 High-Yield Biochemistry & Molecular Mechanisms 20.3 Integrated Pharmacology Strategy & Exam-Day Execution
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes
Key Takeaways Explain This Topic AI
Peptide hormones act via membrane receptors (GPCR or receptor tyrosine kinase) with second messengers; steroid and thyroid hormones act via nuclear receptors that regulate transcription; catecholamines and some amino-acid–derived hormones use membrane GPCRs.
Anterior pituitary hormones are driven by hypothalamic releasing/inhibiting factors; posterior pituitary stores ADH and oxytocin made in supraoptic and paraventricular nuclei.
Negative feedback is the default control loop (e.g., cortisol → CRH/ACTH; T3/T4 → TRH/TSH; IGF-1 → GH); prolactin is mainly under tonic dopamine inhibition.
Prolactinoma causes hypogonadism and galactorrhea; GH excess causes acromegaly/gigantism with elevated IGF-1; Cushing disease is pituitary ACTH excess; Sheehan is postpartum ischemic pituitary necrosis.
Central DI is ADH deficiency (high plasma osmolality, dilute urine, responds to desmopressin); nephrogenic DI is renal resistance; SIADH is inappropriate ADH with euvolemic hypotonic hyponatremia and inappropriately concentrated urine.
Last updated: August 2026
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes
Quick Answer: Peptide hormones → membrane GPCR/RTK + second messengers; steroids/thyroid → nuclear receptors. Hypothalamus drives anterior pituitary with releasing/inhibiting hormones; posterior lobe releases ADH and oxytocin. Feedback closes most loops. Prolactinoma, acromegaly, Cushing disease, Sheehan, central vs nephrogenic DI, and SIADH are the high-yield clinical packages.
Endocrine physiology on the CBSE is mechanism-first: how the signal arrives, which cell type secretes which product, how feedback should look when one level is fixed high or low, and which lesion breaks volume or osmolality control. Build a signaling map, then hang the hypothalamic–pituitary axes and the classic sellar lesions on it.
Hormone Classes and Receptor Logic
Hormones fall into three practical signaling families for exams.
Peptide and protein hormones (e.g., insulin, glucagon, GH, prolactin, ACTH, TSH, FSH, LH, PTH, ADH, oxytocin, hypothalamic releasing hormones) are hydrophilic. They cannot freely cross the plasma membrane, so they bind cell-surface receptors . Two major membrane classes dominate:
G protein–coupled receptors (GPCRs) — seven-transmembrane receptors coupled to heterotrimeric G proteins. Gs activates adenylyl cyclase → ↑cAMP → protein kinase A. Gi inhibits adenylyl cyclase. Gq activates phospholipase C → IP3 (Ca2+ release) and DAG (protein kinase C). Many anterior-pituitary–tropic receptors and catecholamine receptors use this pattern (e.g., ACTH via Gs-cAMP; TRH via Gq; ADH V1 via Gq, V2 via Gs).
Receptor tyrosine kinases (RTKs) and related kinase-linked receptors — ligand binding triggers dimerization and autophosphorylation (classic insulin and many growth-factor receptors) or JAK–STAT recruitment (GH and prolactin use cytokine-receptor–associated JAK2–STAT pathways rather than classical RTK catalytic domains). Downstream MAPK, PI3K–Akt, and transcriptional programs follow.
Steroid hormones (cortisol, aldosterone, estrogen, progesterone, testosterone, vitamin D as a steroid-like secosteroid) and thyroid hormones (T3/T4) are lipophilic. They cross membranes and bind intracellular nuclear receptors (type I cytosolic for many steroids with nuclear translocation; type II nuclear for thyroid hormone and others already DNA-associated). Ligand-bound receptors act as transcription factors at hormone response elements— slower genomic effects , though some non-genomic membrane actions exist at the margin of Step 1 emphasis.
Amino-acid–derived hormones split: catecholamines (tyrosine → dopamine, NE, epinephrine) behave like peptides at membrane GPCRs; thyroid hormones (tyrosine + iodine) behave like steroids at nuclear receptors; melatonin (tryptophan-derived) uses membrane receptors.
Class Examples Receptor location Typical speed / mechanism
Peptide/protein Insulin, GH, ACTH, ADH, PTH Membrane (RTK, JAK–STAT, GPCR) Seconds–minutes; second messengers, kinase cascades
- Steroid Cortisol, aldosterone, sex steroids Nuclear (genomic) Hours; gene transcription
- Amino-acid derived Catecholamines Membrane GPCR Fast
- Amino-acid derived T3/T4 Nuclear Genomic, like steroids
Storage pearl: Peptides are stored in secretory granules and released on stimulus. Steroids are synthesized on demand from cholesterol (limited preformed store). Thyroid hormone is stored as colloid thyroglobulin—an exception among "nuclear" hormones.
Hypothalamic Control of the Anterior Pituitary
Hypothalamic neurons release hypophysiotropic hormones into the hypophyseal portal system at the median eminence; these peptides reach anterior pituitary (adenohypophysis) cells at high local concentration.
- Hypothalamic factor Effect on anterior pituitary Anterior product
- TRH Stimulates TSH (also mild prolactin release)
- CRH Stimulates ACTH
- GnRH (pulsatile) Stimulates FSH, LH
- GHRH Stimulates GH
- Somatostatin Inhibits GH (and TSH)
- Dopamine (PIF) Inhibits Prolactin
- PRH (less emphasized) Stimulates Prolactin
Anterior pituitary cell types ("FLAT PiG" mnemonic variants):
- Corticotrophs → ACTH (POMC product; MSH and β-endorphin share the precursor)
- Thyrotrophs → TSH
- Gonadotrophs → FSH, LH
- Somatotrophs → GH
- Lactotrophs → prolactin
Acidophils traditionally stain GH and prolactin; basophils stain ACTH, TSH, FSH/LH—useful histology trivia when vignettes mention tinctorial class.
Pulsatility matters: Continuous GnRH suppresses gonadotrophs (basis of GnRH agonist "flare then down-regulation"); pulsatile GnRH supports fertility. Stress, illness, and hyperprolactinemia can suppress GnRH drive → hypogonadotropic hypogonadism.
Posterior Pituitary: ADH and Oxytocin
The posterior pituitary (neurohypophysis) does not synthesize its hormones. Magnocellular neurons in the supraoptic and paraventricular nuclei make ADH (vasopressin) and oxytocin , transport them down axons via the pituitary stalk, and release them into systemic capillaries.
ADH: Primary stimuli are increased plasma osmolality (osmoreceptors) and substantial volume depletion/hypotension (baroreceptors). V2 receptors (renal collecting-duct principal cells, Gs-cAMP) insert AQP2 water channels → free-water reabsorption. V1 receptors (vascular smooth muscle, Gq) mediate vasoconstriction at high concentrations.
Oxytocin: Milk ejection (myoepithelial contraction) and uterine contraction; positive feedback in labor is the classic exam story.
Stalk compression classically raises prolactin (loss of dopamine inhibition) while it can impair other anterior hormones and, if severe, ADH/oxytocin release.
Feedback Loops
Most axes use long-loop negative feedback : peripheral hormone inhibits hypothalamic and pituitary drive.
Cortisol inhibits CRH and ACTH.
Free T3/T4 inhibit TRH and TSH.
IGF-1 and GH provide negative feedback on GHRH/GH; somatostatin provides inhibition.
Sex steroids and inhibin modulate GnRH/FSH/LH (context-specific positive feedback of estrogen at midcycle is the ovulation exception).
Prolactin is unusual: primary control is tonic dopaminergic inhibition from the hypothalamus; TRH can stimulate prolactin (hypothyroidism → hyperprolactinemia on exams).
Interpretation skill: High peripheral hormone + high tropic hormone suggests primary pituitary (or ectopic tropic) autonomy. High peripheral + suppressed tropic suggests peripheral autonomy or exogenous hormone. Low peripheral + high tropic suggests primary end-organ failure. Low peripheral + low/inappropriately normal tropic suggests central (hypothalamic/pituitary) failure.
Pituitary Adenomas and Mass Effects
Most adenomas are benign; clinical effects come from hormone excess and/or mass effect (headache, bitemporal hemianopia from optic chiasm compression, hypopituitarism of remaining axes).
Prolactinoma
Most common functioning adenoma. Hyperprolactinemia inhibits GnRH → low FSH/LH → hypogonadism (amenorrhea, infertility, decreased libido, osteoporosis risk). Galactorrhea may occur. Dopamine agonists ( cabergoline, bromocriptine ) shrink many prolactinomas and lower prolactin—first-line medical therapy is classic.
Acromegaly / Gigantism
GH-secreting somatotroph adenoma. Before epiphyseal closure → gigantism ; after → acromegaly (enlarged hands/feet, coarsened facies, prognathism, organomegaly, insulin resistance/diabetes, cardiomyopathy, sleep apnea, colon polyps risk). Screen with IGF-1 ; confirm with failure of GH suppression on oral glucose tolerance testing in appropriate protocols. Somatostatin analogs, GH-receptor antagonist (pegvisomant), surgery, and radiation appear in treatment outlines.
Cushing Disease
Cushing disease = pituitary ACTH-secreting adenoma (to be distinguished from Cushing syndrome , the broader hypercortisolism phenotype). High ACTH → bilateral adrenal hyperplasia → high cortisol. High-dose dexamethasone often suppresses pituitary ACTH somewhat more than ectopic ACTH, though exams emphasize patterns over perfect numbers: pituitary Cushing often partially suppressible; ectopic ACTH (e.g., small cell lung cancer) often not; adrenal cortisol-producing tumor suppresses ACTH.
Nonfunctioning adenomas
Often present later with mass effect and hypopituitarism; may secrete inactive subunits. Stalk effect can raise prolactin modestly (usually lower than macroadenoma prolactinomas).
Sheehan Syndrome
Postpartum ischemic necrosis of the enlarged pregnant pituitary after severe obstetric hemorrhage/hypotension. Failure to lactate (prolactin loss), persistent amenorrhea, and progressive anterior hypopituitarism; posterior DI is less common than anterior failure but can occur. Acute adrenal crisis risk if ACTH is lost—stress-dose steroids conceptually matter.
Diabetes Insipidus vs SIADH
- Feature Central DI Nephrogenic DI SIADH
- Problem ADH deficiency Kidney resists ADH Too much ADH effect
- Plasma osmolality High High Low
- Urine Inappropriately dilute Inappropriately dilute Inappropriately concentrated
- Volume Polyuria, polydipsia; can dehydrate Same Euvolemic hyponatremia
- Desmopressin Concentrates urine Little response Not the concept—water restrict
Central DI causes: idiopathic, trauma/surgery, tumors, infiltrative disease, autoimmune. Nephrogenic DI: lithium, hypercalcemia, hereditary V2/AQP2 defects. Water deprivation test logic: DI patients continue to put out dilute urine despite rising plasma osmolality; desmopressin distinguishes central (response) from nephrogenic (no response).
SIADH: euvolemic hypotonic hyponatremia, high urine osmolality and urine Na+ (natriuresis), low plasma uric acid often, normal thyroid/adrenal. Causes: CNS disease, lung disease (including small cell carcinoma ectopic ADH), drugs (SSRIs, carbamazepine), pain/nausea. Free water is retained; treatment concepts emphasize fluid restriction and addressing cause; demeclocycline/vaptans appear in advanced outlines.
Integration for CBSE Vignettes
When a stem shows amenorrhea + galactorrhea, think prolactin and dopamine tone. When hands/feet enlarge with diabetes and coarse features, think GH/IGF-1. When postpartum hemorrhage is followed by failure to lactate, think Sheehan. When polyuria with high plasma osmolality and low urine osmolality appears, decide DI vs primary polydipsia, then central vs nephrogenic. When euvolemic hyponatremia with concentrated urine appears after pneumonia or SSRI start, think SIADH—not volume depletion alone.
Master the receptor class, the portal anatomy, the feedback pattern, and the five classic clinical packages above, and most hypothalamic–pituitary CBSE items become pattern recognition rather than memorization noise.